All News

YouTube Still

RheumNow Podcast – ACR Convergence Begins (11.5.2021)

d Jack Cush, MD

Dr. Cush reviews the news, and kicks off ACR21 learning and how to take in the annual meeting.

Read Article
together solution

Polyautoimmunity: axSpA and Familial Mediterranean Fever

d Rachel Tate, DO

Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of Familial Mediterranean Fever (FMF) and axial spondyloarthritis (axSpA), remains rare. In fact, we believe the rate to be between 0.5% and 7.5%.

Read Article
Plaquenil.HCQ_.pills_.jpg (keep)

Prolonging the Controversy of Hydroxychloroquine

d Kathryn H. Dao, M.D.

Since the start of the pandemic, hydroxychloroquine (HCQ) was forced into the limelight for the prevention/treatment of COVID-19.

Read Article
shoulder.exam_.jpg

ACR21 Previews from Creaky Joints

d Jack Cush, MD

CreakyJoints will present 11 posters and two oral presentations at ACR 2021. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system. 

Read Article
ACRmtg.jpg (keep)

Industry Press Releases - BMS, Abbvie, UCB, Janssen

d Jack Cush, MD

The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021.  Below is a listing of some of their best studies for you to review and look for in the meeting.

Read Article
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

@DoctorYasmin concludes her wonderful, innovative keynote address by noting 2 things she would like to see change moving forward: 1. How we tend to the wellness of providers 2. Improving communication amongst medical colleagues & communication to the public. #ACR21 @RheumNow https://t.co/BdyVgVr0on
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu) in our patients! Much more work to be done here in rheumatology! @DrDavidKarp at #ACR21 opening session @rheumnow

Bella Mehta bella_mehta ( View Tweet)

@DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
Eric Dein ericdeinmd ( View Tweet)
@DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation during a pandemic? To improve health literacy, we need to learn how to engage better: - understand the issues/public thinking - targeted messaging to different communities - avoid medical hubris @RheumNow https://t.co/FLvPvX3UJc
David Liew drdavidliew ( View Tweet)
@DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vaccines." Its a great opportunity for us to learn, research, and educate about the flu, shingles, pneumonia, and more vaccines. 💉 @RheumNow #ACR21

Eric Dein ericdeinmd ( View Tweet)

"I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need systems that are more resilient" @DoctorYasmin on lessons learned from #COVID to prepare for future challenges/outbreaks #ACR21 @RheumNow https://t.co/DAdCH80uQ5
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
@DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one size fits all" method in tackling vaccine hesitancy. She emphasizes the need for targeted messaging & the ideology that vaccination is anti-American must be debunked! #ACR21 @RheumNow https://t.co/cU33XEOYhM
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
"If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session. We need systems that don't need a crisis to shine on them to progressively change for the better. @RheumNow https://t.co/uf4OO2VpHV
David Liew drdavidliew ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

So excited to cover the annual #ACR21 Convergence Conference aside the amazing @Rheumnow Faculty team. A hearty congratulations to our wonderful leader, Dr. Jack Cush @RheumNowNews, for the well-earned designation as an ACR Master. https://t.co/v6fAyqH1CU
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush. It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6

Links:

David Liew drdavidliew ( View Tweet)

Intensive RA Rx in the TITRATE study showed Disease activity & less remission in in obese patients, but Anxiety, depression and health perceptions were associated with higher pain and fatigue scores. These are unaccounted for in Rx strategies https://t.co/B8izEjfz8P

Links:

Dr. John Cush RheumNow ( View Tweet)

How I Treat Rheumatoid Arthritis My Stepwise Approach to DMARD, Biologic and Targeted Synthetic Use in RA patients QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 (November 5-9, 2021) https://t.co/jizbQ0Bgxq https://t.co/fXLheKv5dw

Links:

Dr. John Cush RheumNow ( View Tweet)
Treat-to-Target Works in Gout With No Cardiac Toxicity New research presented this week at ACR Convergence shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. #ARC21 Read more... https://t.co/r2usSxNnfZ https://t.co/GIgAP3T2hd

Links:

Dr. John Cush RheumNow ( View Tweet)
×